In-Person Access Only | 6.0 CE/CME Credits & MOC Points
All programs remain free. Registrations will require a credit card as a cancellation hold. A fee of $99 will only be incurred in the event of a no-show or cancellation within 5 days without written confirmation to the Total Health Program Team.
Total Health’s 2026 ASCO Direct™ Gastrointestinal Cancer Conference is an officially licensed ASCO Direct™ meeting. This Post-ASCO Gastrointestinal Cancers Symposium Review highlights key abstracts from top-rated presentations, providing attendees with direct access to the latest research and strategies in GI oncology education. The accredited meeting will be hosted as an in-person meeting only available exclusively to registered participants.
Conference Agenda
Saturday, February 7, 2026
8:00 AM
Coffee and Exhibits
8:30 AM
Program Chair Welcome
Nelson Yee MD, PhD, RPh | Penn State Cancer Institute
8:40 AM
Organ Preservation Strategies GEJ/Gastric Adenocarcinoma: Ready for Prime Time?
Benjamin Weinberg, MD | Georgetown University
9:00 AM
Locally Advanced and Borderline Resectable Pancreatic Cancer: Multidisciplinary Approaches
Greg Heestand, MD | Stanford Medicine
9:20 AM
Navigating Early Onset CRC – Diagnosis Through Survivorship
Sunnie Kim, MD | UC Health/University of Colorado
9:40 AM
Breakfast and Exhibits
9:55 AM
Non-CME Breakfast - Incyte Zynyz - Redefining the Treatment of Squamous Cell Carcinoma of the Anal Canal (SCAC) | ZYNYZ® (retifanlimab-dlwr) The First and Only FDA-Approved PD-1 Inhibitor for Adults with Inoperable Locally Recurrent or Metastatic SCAC
Girish Kunapareddy, MD | Union Medical Group
10:40 AM
Using Artificial Intelligence in the Gastrointestinal Cancers
Arturo Loaiza-Bonilla, MD, MSEd, FACP | St. Lukes University Health Network
11:00 AM
Managing Liver Tumors with Liver Dysfunction: Balancing Tumor Control with Hepatotoxicity
Aiwu He, MD, PhD | Columbia University Irving Medical Center
11:20 AM
Unresectable Colorectal Liver Metastases: Liver-Directed Approaches and Transplantation
Nelson Yee MD, PhD, RPh | Penn State Cancer Institute
11:40 AM
Lunch and Exhibits
11:55 AM
Non-CME Lunch - Histosonics - Histotripsy for Medical Oncology: 1-Year Outcomes, Publications & Proposed Trials
Young Hong, MD, MPH, FACS, FSSO | MD Anderson Cancer Center at Cooper
12:40 PM
Housekeeping and Survey
12:50 PM
Emerging Screening Modalities in Pancreatic & Gastric Cancers
Rachael Safyan, MD | Fred Hutchinson Cancer Center
1:10 PM
Advances in Targeted Therapies: BRAF
Christopher Cann, MD | Fox Chase Cancer Center
1:30 PM
Harnessing Genomics for Personalized Treatment in GI Malignancies
Michael Hall, MD | Fox Chase Cancer Center
1:50 PM
Adjourn
Sunday, February 8, 2026
8:00 AM
Coffee and Exhibits
8:30 AM
Program Chair Welcome
Kim Reiss, MD | Abramson Cancer Center, University of Pennsylvania
8:40 AM
Bispecifics, ADCs & Cellular Therapies Emerging Across GI Malignancies
Daniel Lin, MD, MSc | Thomas Jefferson University
9:00 AM
Balancing Local and System Control in Gastric and Gastroesophageal Cancers: Multidisciplinary Approaches (Pre-Recorded)
Arthur Winer, MD| Inova Schar Cancer Institute
9:20 AM
Panel Discussion: Esophageal and Gastric Cancers
Rachael Safyan, MD (Moderator) | Fred Hutchinson Cancer Center
Steven Maron, MD | Memorial Sloan Kettering Cancer Center
Daniel Lin, MD, MSc | Thomas Jefferson University
9:40 AM
Breakfast and Exhibits
9:55 AM
Non-CME Breakfast - Taiho - LONSURF + bevacizumab for the Treatment of 3L Metastatic Colorectal Cancer
Midhun Malla, MD, MS | The University of Alabama at Birmingham
10:40 AM
Navigating Complexity in Biliary Tract Cancers: A Case-Based Discussion of Evolving Therapeutic Strategies
Haley Ellis, MD | Massachusetts General Hospital
11:00 AM
Managing T2 Rectal Cancer
Midhun Malla, MD, MS | The University of Alabama at Birmingham
11:20 AM
Optimizing CRC Therapy with ctDNA
Nicholas Hornstein, MD | Northwell Health
11:40 AM
Lunch and Exhibits
12:00 PM
Updates in Metastatic Pancreatic Cancer
Kim Reiss, MD | Abramson Cancer Center, University of Pennsylvania
12:20 PM
Integrative Oncology: Supportive Care Advances
Kelsey Lau-Min, MD | Massachusetts General Hospital
12:40 PM
Future Directions: What to Expect by ASCO 2027
Steven Maron, MD | Memorial Sloan Kettering Cancer Center
1:00 PM
Adjourn
Agenda Subject To Change. All times are EST.
-
Review and analyze the latest therapeutic advances for the treatment and management of GI cancer
Apply new data and therapeutic advances into guideline-driven treatment strategies to improve the care of patients with GI cancers, neuroendocrine tumors, and hepatocellular cancers
Identify subpopulations of patients with gastrointestinal cancers most likely to benefit from a specific treatment plan based on prognostic or predictive markers
Evaluate the role of ctDNA and MRD in GI cancers
-
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 6.00 ANCC contact hours.
Physicians (ACCME) Credit Designation
Amedco LLC designates this live activity for a maximum of 6.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacists and Pharmacy Technicians (ACPE) Credit Designation
Amedco LLC designates this activity for a maximum of 6.00 knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor.
American Board of Internal Medicine (ABIM) MOC Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.00 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. You must request your certificate within 45 days of the activity to meet the deadline for submission to PARS.
-
Free registration for all healthcare providers
Expert sessions that present the most clinically relevant data, research, and clinical strategies
Enduring video content for watching at your leisure
Real-time discussion and debate
Networking with peers, colleagues, and medical professionals
Access to the latest industry information and resources
Catered meals through-out the program